Skip to content
ClinCalc Pro
Menu
Anthelmintic (benzimidazole)

Albendazole

Brand names: Eskazole, Zentel, Albenza

Albendazole is a broad-spectrum benzimidazole anthelmintic used to treat a range of helminth infections including hydatid disease, neurocysticercosis and various intestinal and tissue nematode infections.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It binds parasite beta-tubulin, inhibiting microtubule polymerisation and impairing glucose uptake, which depletes the parasite's energy stores.

Prescribing in practice

  • Can cause bone marrow suppression and hepatotoxicity, particularly with prolonged courses, so monitor blood counts and liver function.
  • It is teratogenic in animals and should be avoided in pregnancy, with pregnancy excluded before treatment where appropriate.
  • In neurocysticercosis, corticosteroid cover and anticonvulsant use may be needed to manage inflammatory responses, as directed by specialist guidance.

Monitoring

Monitor full blood count and liver function during prolonged or repeated treatment courses.

Counselling the patient

  • Take with a fatty meal to improve absorption when treating tissue infections.
  • Use effective contraception during and for a period after treatment.
  • Report any fever, sore throat, jaundice or unusual tiredness.

Evidence & guidelines

Albendazole is recommended by the World Health Organization for soil-transmitted helminth control and is standard therapy for echinococcosis and neurocysticercosis.

Reference: WHO Guidelines on Echinococcosis 2009 / 2022 update; CDC Parasitic Disease Treatment Guidance; NICE CKS Worms; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.